Chronic hepatitis C virus hepatitis and psoriasis: No longer a contraindication to interferon use in the era of biological agents?. (April 2013)

• Record Type: Journal Article
• Authors: Bartalesi, Filippo; Salomoni, Elena; Cavallo, Annalisa; Corti, Giampaolo; Pimpinelli, Nicola; Bartoloni, Alessandro; Taliani, Gloria
• Is Part Of: Scandinavian journal of infectious diseases. Volume 45:Number 4(2013:Apr.)
• Page Start: 320
• Page End: 323
• Publication Date: 2013-04
• Subjects: Communicable diseases -- Periodicals; Infection -- Periodicals; 616.9
• DOI: 10.3109/00365548.2012.720026
• Languages: English
• ISSNs: 0036-5548

Abstract

<abstract> <title>Abstract</title> <p>We describe a patient with severe psoriasis and hepatitis C simultaneously treated with pegylated interferon alpha (peg-IFNα) plus ribavirin and etanercept, whose skin lesions improved and who reached a sustained virological response. This case suggests that refractory psoriasis can today no longer be considered as a contraindication for combined hepatitis C virus treatment.</p> </abstract>